Literature DB >> 19384953

Genetic variants in pigmentation genes, pigmentary phenotypes, and risk of skin cancer in Caucasians.

Hongmei Nan1, Peter Kraft, David J Hunter, Jiali Han.   

Abstract

Human pigmentation is a polygenic quantitative trait with high heritability. Although a large number of single nucleotide polymorphisms (SNPs) have been identified in pigmentation genes, very few SNPs have been examined in relation to human pigmentary phenotypes and skin cancer risk. We evaluated the associations between 15 SNPs in 8 candidate pigmentation genes (TYR, TYRP1, OCA2, SLC24A5, SLC45A2, POMC, ASIP and ATRN) and both pigmentary phenotypes (hair color, skin color and tanning ability) and skin cancer risk in a nested case-control study of Caucasians within the Nurses' Health Study (NHS) among 218 melanoma cases, 285 squamous cell carcinoma (SCC) cases, 300 basal cell carcinoma (BCC) cases and 870 common controls. We found that the TYR Arg402Gln variant was significantly associated with skin color (p-value = 7.7 x 10(-4)) and tanning ability (p-value = 7.3 x 10(-4)); the SLC45A2 Phe374Leu variant was significantly associated with hair color (black to blonde) (p-value = 2.4 x 10(-7)), skin color (p-value = 1.1 x 10(-7)) and tanning ability (p-value = 2.5 x 10(-4)). These associations remained significant after controlling for MC1R variants. No significant associations were found between these polymorphisms and the risk of skin cancer. We observed that the TYRP1 rs1408799 and SLC45A2 1721 C>G were associated with melanoma risk (OR, 0.77; 95% CI, 0.60-0.98 and OR, 0.75; 95% CI, 0.60-0.95, respectively). The TYR Ser192Tyr was associated with SCC risk (OR, 1.23; 95% CI, 1.00-1.50). The TYR haplotype carrying only the Arg402Gln variant allele was significantly associated with SCC risk (OR, 1.35; 95% CI, 1.04-1.74). The OCA2 Arg419Gln and ASIP g.8818 A>G were associated with BCC risk (OR, 1.50; 95% CI, 1.06-2.13 and OR, 0.73; 95% CI, 0.53-1.00, respectively). The haplotype near ASIP (rs4911414[T] and rs1015362[G]) was significantly associated with fair skin color (OR, 2.28; 95% CI, 1.46-3.57) as well as the risks of melanoma (OR, 1.68; 95% CI, 1.18-2.39) and SCC (OR, 1.54; 95% CI, 1.08-2.19). These associations remained similar after adjusting for pigmentary phenotypes and MC1R variants. The statistical power of our study was modest and additional studies are warranted to confirm the associations observed in the present study. Our study provides evidence for the contribution of pigmentation genetic variants, in addition to the MC1R variants, to variation in human pigmentary phenotypes and possibly the development of skin cancer.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19384953      PMCID: PMC2700213          DOI: 10.1002/ijc.24327

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  66 in total

1.  Reproducibility of a self-administered questionnaire for assessment of melanoma risk.

Authors:  J Westerdahl; H Anderson; H Olsson; C Ingvar
Journal:  Int J Epidemiol       Date:  1996-04       Impact factor: 7.196

2.  Risk factors for basal cell carcinoma in a prospective cohort of women.

Authors:  D J Hunter; G A Colditz; M J Stampfer; B Rosner; W C Willett; F E Speizer
Journal:  Ann Epidemiol       Date:  1990-10       Impact factor: 3.797

3.  Chromosomal structure of the human TYRP1 and TYRP2 loci and comparison of the tyrosinase-related protein gene family.

Authors:  R A Sturm; B J O'Sullivan; N F Box; A G Smith; S E Smit; E R Puttick; P G Parsons; I S Dunn
Journal:  Genomics       Date:  1995-09-01       Impact factor: 5.736

Review 4.  Molecular genetics of oculocutaneous albinism.

Authors:  R A Spritz
Journal:  Hum Mol Genet       Date:  1994       Impact factor: 6.150

Review 5.  Molecular and developmental genetics of mouse coat color.

Authors:  I J Jackson
Journal:  Annu Rev Genet       Date:  1994       Impact factor: 16.830

6.  Proopiomelanocortin-derived peptides are synthesized and released by human keratinocytes.

Authors:  E Schauer; F Trautinger; A Köck; A Schwarz; R Bhardwaj; M Simon; J C Ansel; T Schwarz; T A Luger
Journal:  J Clin Invest       Date:  1994-05       Impact factor: 14.808

7.  Autosomal recessive ocular albinism associated with a functionally significant tyrosinase gene polymorphism.

Authors:  K Fukai; S A Holmes; N J Lucchese; V M Siu; R G Weleber; R E Schnur; R A Spritz
Journal:  Nat Genet       Date:  1995-01       Impact factor: 38.330

8.  Structure and function of ASP, the human homolog of the mouse agouti gene.

Authors:  B D Wilson; M M Ollmann; L Kang; M Stoffel; G I Bell; G S Barsh
Journal:  Hum Mol Genet       Date:  1995-02       Impact factor: 6.150

9.  Variants of the melanocyte-stimulating hormone receptor gene are associated with red hair and fair skin in humans.

Authors:  P Valverde; E Healy; I Jackson; J L Rees; A J Thody
Journal:  Nat Genet       Date:  1995-11       Impact factor: 38.330

10.  A gene for the mouse pink-eyed dilution locus and for human type II oculocutaneous albinism.

Authors:  E M Rinchik; S J Bultman; B Horsthemke; S T Lee; K M Strunk; R A Spritz; K M Avidano; M T Jong; R D Nicholls
Journal:  Nature       Date:  1993-01-07       Impact factor: 49.962

View more
  76 in total

1.  MC1R genotype may modify the effect of sun exposure on melanoma risk in the GEM study.

Authors:  Anne Kricker; Bruce K Armstrong; Chris Goumas; Peter Kanetsky; Richard P Gallagher; Colin B Begg; Robert C Millikan; Terence Dwyer; Stefano Rosso; Loraine D Marrett; Nancy E Thomas; Marianne Berwick
Journal:  Cancer Causes Control       Date:  2010-08-19       Impact factor: 2.506

2.  Metazoan innovation: from aromatic amino acids to extracellular signaling.

Authors:  Katrina M Kutchko; Jessica Siltberg-Liberles
Journal:  Amino Acids       Date:  2013-05-21       Impact factor: 3.520

Review 3.  Comprehensive field synopsis and systematic meta-analyses of genetic association studies in cutaneous melanoma.

Authors:  Foteini Chatzinasiou; Christina M Lill; Katerina Kypreou; Irene Stefanaki; Vasiliki Nicolaou; George Spyrou; Evangelos Evangelou; Johannes T Roehr; Elizabeth Kodela; Andreas Katsambas; Hensin Tsao; John P A Ioannidis; Lars Bertram; Alexander J Stratigos
Journal:  J Natl Cancer Inst       Date:  2011-06-21       Impact factor: 13.506

4.  Explicit Modeling of Ancestry Improves Polygenic Risk Scores and BLUP Prediction.

Authors:  Chia-Yen Chen; Jiali Han; David J Hunter; Peter Kraft; Alkes L Price
Journal:  Genet Epidemiol       Date:  2015-05-21       Impact factor: 2.135

5.  Comprehensive candidate gene study highlights UGT1A and BNC2 as new genes determining continuous skin color variation in Europeans.

Authors:  Leonie C Jacobs; Andreas Wollstein; Oscar Lao; Albert Hofman; Caroline C Klaver; André G Uitterlinden; Tamar Nijsten; Manfred Kayser; Fan Liu
Journal:  Hum Genet       Date:  2012-10-11       Impact factor: 4.132

6.  Colloquium paper: human skin pigmentation as an adaptation to UV radiation.

Authors:  Nina G Jablonski; George Chaplin
Journal:  Proc Natl Acad Sci U S A       Date:  2010-05-05       Impact factor: 11.205

7.  Skin cancer was not a potent selective force in the evolution of protective pigmentation in early hominins.

Authors:  Nina G Jablonski; George Chaplin
Journal:  Proc Biol Sci       Date:  2014-08-22       Impact factor: 5.349

Review 8.  UVA tanning is involved in the increased incidence of skin cancers in fair-skinned young women.

Authors:  Sergio G Coelho; Vincent J Hearing
Journal:  Pigment Cell Melanoma Res       Date:  2009-12-02       Impact factor: 4.693

9.  Obesity-related genetic variants, human pigmentation, and risk of melanoma.

Authors:  Xin Li; Liming Liang; Mingfeng Zhang; Fengju Song; Hongmei Nan; Li-E Wang; Qingyi Wei; Jeffrey E Lee; Christopher I Amos; Abrar A Qureshi; Jiali Han
Journal:  Hum Genet       Date:  2013-03-29       Impact factor: 4.132

Review 10.  Was skin cancer a selective force for black pigmentation in early hominin evolution?

Authors:  Mel Greaves
Journal:  Proc Biol Sci       Date:  2014-02-26       Impact factor: 5.349

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.